What is BPC-157?

BPC-157 is a 15 amino acid peptide derived from a sequence in human gastric juice, with an unusually large animal literature: a 2025 systematic review found 36 studies across tendon, ligament, muscle, bone, gut, liver, and nerve injury models, 35 of them preclinical. In people, FDA's 2026 evaluation counted five small human studies totaling fewer than 110 subjects, including a Croatian ulcerative colitis trial. It is not FDA approved.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.